Suchergebnisse - "Ramael, Steven"

PubPharm (50)

1

SDI-118, a novel procognitive SV2A modulator : First-in-human randomized controlled trial including PET/fMRI assessment of target engagement

enthalten in: Frontiers in pharmacology | 2022

von Botermans, W. | Koole, M. | Van Laere, K. | +11

2

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome

enthalten in: The Journal of clinical endocrinology and metabolism | 2021

von Fraser, G. | Obermayer-Pietsch, B. | Laven, J. | +8

CommentIn: J Clin Endocrinol Metab. 2021 Jun 12;:. - PMID 34117885

3

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms : results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)

enthalten in: Menopause (New York, N.Y.) | 2020

von Santoro, N. | Waldbaum, A. | Lederman, S. | +6

CommentIn: Menopause. 2020 Dec;27(12):1347. - PMID 33048862

4

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause

enthalten in: Menopause (New York, N.Y.) | 2020

von Fraser, G. | Lederman, S. | Waldbaum, A. | +5

CommentIn: Menopause. 2020 Apr;27(4):375-376. - PMID 32132443

5

Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist : A Phase 2a Trial

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Depypere, H. | Timmerman, D. | Donders, G. | +5

6

Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI) : Phase 1, Randomized, Open-Label, Parallel-Group Trials

enthalten in: Rheumatology and therapy | 2018

von Ramael, S. | Van Hoorick, B. | Tiessen, R. | +7

7

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor : Translational Studies

enthalten in: Clinical and translational science | 2018

von Rosenbrock, H. | Desch, M. | Kleiner, O. | +12

8

Safety, Tolerability, and Pharmacokinetics of Suvorexant : A Randomized Rising-Dose Trial in Healthy Men

enthalten in: Clinical drug investigation | 2018

von Yee, K. | McCrea, J. | Panebianco, D. | +5

9

Similar Pharmacokinetics of the Adalimumab ($ Humira^{®} $) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe ($ VOLTAIRE^{®} $-AI and $ VOLTAIRE^{®} $-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials

enthalten in: Rheumatology and therapy | 2018

von Ramael, S. | Van Hoorick, B. | Tiessen, R. | +7

10

Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men

enthalten in: Clinical drug investigation | 2018

von Yee, K. | McCrea, J. | Panebianco, D. | +5

1
2
3
4
5
Nächster »
[5]